Medicare Enrolled

Dr. Jorge Rivero Becerra, M.D.

Interventional Pain Medicine Physician · Pittsburgh, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
363 VANADIUM RD, Pittsburgh, PA 15243
4122791231
In practice since 2006 (20 years)
NPI: 1396780409 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rivero Becerra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rivero Becerra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rivero Becerra

Dr. Jorge Rivero Becerra is an interventional pain medicine physician in Pittsburgh, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rivero Becerra performed 2,839 Medicare services across 607 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rivero Becerra received a total of $13,319 from 56 pharmaceutical and/or device companies across 851 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rivero Becerra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 24% volume in PA $13,319 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,839
Medicare services
Top 24% in PA for interventional pain medicine physician
607
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~142 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,462 $0 $2
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
705 $59 $100
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
353 $59 $100
Contrast dye for imaging, lower concentration 72 $0 $40
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
71 $54 $217
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
49 $86 $135
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
48 $165 $465
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
31 $114 $300
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
25 $165 $619
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
23 $81 $145
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,319
Total received (2018-2024)
Avg $1,903/year across 7 years
Top 5% in PA for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
851
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,319 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,084
2023
$1,668
2022
$1,807
2021
$1,401
2020
$1,335
2019
$2,760
2018
$2,263

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$647
ABBVIE INC.
$416
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$244
Collegium Pharmaceutical, Inc.
$210
Boston Scientific Corporation
$198
Indivior Inc.
$70
Virtus Pharmaceuticals LLC
$47
VERTEX PHARMACEUTICALS INCORPORATED
$45
Orexo US, Inc.
$45
Valinor Pharma, LLC
$45
SCILEX PHARMACEUTICALS INC.
$41
Braeburn Inc.
$32
Bioventus LLC
$28
AppliedVR Inc
$17
Top 3 companies account for 62.7% of 2024 payments
All-time payments by company (2018-2024) ›
Collegium Pharmaceutical, Inc.
$1,748
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,335
Abbott Laboratories
$1,301
Indivior Inc.
$836
ABBVIE INC.
$817
Boston Scientific Corporation
$673
Scilex Pharmaceuticals Inc.
$570
TerSera Therapeutics LLC
$425
PFIZER INC.
$401
Horizon Therapeutics plc
$399
US WorldMeds, LLC
$372
AbbVie Inc.
$341
Sentynl Therapeutics, Inc.
$341
SCILEX PHARMACEUTICALS INC.
$302
Daiichi Sankyo Inc.
$254
Kaleo, Inc.
$228
Virtus Pharmaceuticals LLC
$201
BOSTON SCIENTIFIC CORPORATION
$189
Nuvectra Corporation
$182
RedHill Biopharma Inc.
$178
BSN Medical Inc
$166
Horizon Pharma plc
$151
Almatica Pharma LLC
$150
ASSERTIO THERAPEUTICS, Inc.
$132
Pernix Therapeutics Holdings, Inc.
$130
Orexo US, Inc.
$126
GRT US Holding, Inc.
$124
Purdue Pharma L.P.
$100
Medtronic USA, Inc.
$85
Bioventus LLC
$84
PROTEGA PHARMACEUTIALS INC
$71
Electronic Waveform Lab, Inc.
$70
Shionogi Inc
$68
Jazz Pharmaceuticals Inc.
$62
Valinor Pharma, LLC
$59
SI-BONE, Inc.
$54
PROTEGA PHARMACEUTIALS LLC
$50
Braeburn Inc.
$45
VERTEX PHARMACEUTICALS INCORPORATED
$45
Flexion Therapeutics, Inc.
$42
BioDelivery Sciences International, Inc.
$41
Vertical Pharmaceuticals, LLC
$41
Takeda Pharmaceuticals U.S.A., Inc.
$41
SI-BONE, INC.
$38
SANOFI-AVENTIS U.S. LLC
$36
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$29
ASSERTIO THERAPEUTICS, INC.
$29
Radius Health, Inc.
$24
ARBOR PHARMACEUTICALS, INC.
$20
Neuronetics, Inc.
$20
Axsome Therapeutics, Inc.
$18
AppliedVR Inc
$17
Teva Pharmaceuticals USA, Inc.
$15
Nevro Corp.
$15
Currax Pharmaceuticals LLC
$13
Zyla Life Sciences
$13
Top 3 companies account for 32.9% of all-time payments
Associated products mentioned in payments ›
ACTIMOVE · ADAPTIVESTIM · AJOVY · Algovita · Amitiza · Axium INS DRG IPG · BELBUCA · BRIXADI · BUNAVAIL 2.1 mg 30-count box · Belbuca · DRG leads · DUEXIS · DUROLANE · Durolane · EMBEDA · ETERNA · EVZIO · Evzio · FLECTOR · FLECTOR PATCH · GELSYN-3 · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · Gralise · Horizant · IFUSE IMPLANT · INTELLIS · KRYSTEXXA · LACTULOSE · LEVORPHANOL TARTRATE · LORZONE · LYRICA · Levorphanol · Levorphanol Tartrate · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Motegrity · Movantik · NAPRELAN · NEUROSTAR TMS THERAPY SYSTEM · ONZETRA XSAIL · OXYCONTIN · Octrode SCS Leads · Omnia · PENNSAID · PENTA · PRIALT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim XR IPG · Prodigy Family of SCS IPGs · QULIPTA · Qutenza · RELISTOR · REYVOW · ROXYBOND · RelieVRx · Roxybond · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRIX · SUBLOCADE · SYMPROIC · SYNVISC-ONE · Sunosi · Symproic · Tymlos · UBRELVY · VIMOVO · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zubsolv · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for interventional pain medicine physician in PA.

Looking for an interventional pain medicine physician in Pittsburgh?
Compare interventional pain medicine physicians in the Pittsburgh area by procedure volume, costs, and industry payment transparency.
Browse interventional pain medicine physicians nearby

Geographic Context

Interventional pain medicine physicians within 10 mi
7
Per 100K population
0.6
County median income
$76,393
Nearest hospital
ST CLAIR HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rivero Becerra is a clinical cardiology specialist, with above-average Medicare volume (top 24% in PA), with low-engagement industry engagement in the top 5% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rivero Becerra experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Rivero Becerra performed 1,462 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rivero Becerra receive payments from pharmaceutical companies?
Yes. Dr. Rivero Becerra received a total of $13,319 from 56 companies across 851 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rivero Becerra's costs compare to other interventional pain medicine physicians in Pittsburgh?
Dr. Rivero Becerra's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rivero Becerra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →